Education
About Us
Working with TipRanks
Follow Us
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 42.32M | $ 25.47M | $ 31.42M | $ 29.32M | - |
| Operating Income | $ -16.33M | $ -43.91M | $ -51.83M | $ -33.92M | $ -27.16M |
| EBITDA | $ -22.64M | $ -32.52M | $ -46.96M | $ -34.94M | $ -26.12M |
| Net Income | $ -24.54M | $ -33.28M | $ -45.74M | $ -37.20M | $ -25.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 38.68M | $ 95.49M | $ 153.56M | $ 105.01M | $ 141.10M |
| Total Debt | $ 0.00 | $ 13.10M | $ 13.84M | $ 15.93M | $ 16.22M |
| Net Debt | $ -26.37M | $ -46.07M | $ -103.92M | $ -54.50M | $ -87.94M |
| Total Liabilities | $ 11.92M | $ 67.56M | $ 102.81M | $ 73.98M | $ 89.75M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -53.99M | $ -60.97M | $ -8.61M | $ -48.62M | $ -54.93M |
| Operating Cash Flow | $ -53.82M | $ -59.93M | $ -7.66M | $ -45.90M | $ -52.47M |
| Investing Cash Flow | |||||
| Financing Cash Flow |